Skip Navigation
Johns Hopkins Bloomberg School of Public Health
Bookmark and Share

Featured IVAC Publications

2016 Pneumonia and Diarrhea Progress Report: Reaching Goals Through Action and Innovation

State of PCV Use and Impact Evaluations (March 2016)

State of Rotavirus Vaccine Use and Impact Evaluations (March 2016)

Rotavirus: Common, Severe, Devastating, Preventable

Return on Investment from Child Immunization in Low- and Middle-Income Countries, 2011-20

Effect of Hib vaccination without a booster dose on invasive Hib disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya

Basket Funds: A Pooled Arrangement to Finance Primary Health Care Delivery and Address the Funding Flow in Nigeria

Coverage, Cost, and Safety Impacts of Primary Container Choice

Global Vaccine Introduction Status

IVAC has launched a new, interactive platform that enables users to instantly visualize real-time information on vaccine use, product type, coverage, and impact assessments.

VIEW-hub - Now live!

Learn more about the VIEW-hub platform

Download the September 2016 VIEW-hub report

Advocacy for Immunisation Online Tool

A platform, jointly developed by PATH and IVAC, designed to help vaccine champions advocate for improved immunisation systems and access to vaccines.

Check out the tools, resources, guidelines, and more!

Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants: A Landscape Analysis of Evidence Supporting Different Schedules - Supplement in The Pediatric Infectious Disease Journal

The most comprehensive review of dosing schedules for PCV in various populations across time was published in the January 2014 issue of the PIDJ. To access this supplement, please click here.

Hib Initiative Supplement in Journal of Pediatrics

In a special supplement sponsored by the Hib Initiative, more than 115 authors contribute to the evidence for Hib vaccines in developing countries. It includes articles on vaccine impact, disease surveillance, cost-effectiveness, morbidity, and other key topics. To read this important supplement, please click here.

Connect With Us

Subscribe to the IVAC newsletter, Focus on Vaccine Access:

Latest Updates

American leaders and poor children deserve the same opportunity to beat pneumonia 

New Malawi PCV13 Pneumonia Study Shows Substantial Impact and Uses New Measures

IVAC Names Dr. Chizoba Wonodi Nigeria Country Director

IVAC Releases the 2016 Pneumonia & Diarrhea Progress Report

Pneumonia in the Headlines and Around the World

Experts in Dengue Control Form New Alliance to Bridge Vaccine and Vector Approaches and Expand Efforts to Zika and other Aedes-Transmitted Diseases

IVAC Launches The Pneumonia Newsletter

Gaps in Vaccine Coverage Highlighted With New Report and Online Tool


Good immunization data is not just for experts and nerds, it is for us all

IVAC Launches VIEW-hub Interactive Vaccine Data Visualization Platform

Recent Publications Highlight the Costs of Pneumococcal Disease and Impact of Vaccines in The Gambia

WHO Recommends Dengvaxia® Use in Areas of High Dengue Risk

IVAC Joins Newly Launched Dose Per Container Partnership (DPCP) Led by JSI

WHO Launches a New Vaccine Pipeline Tracker

The Potential Economic Impact of the Zika Virus

Rwanda Study Demonstrates the Benefits of Routine Vaccination Against Rotavirus in Low-Income Settings

Thailand Study Uncovers the High Burden of Pneumococcal Pneumonia in Adults

Anita Shet, MD, PhD, Joins IVAC as Pediatric Infectious Disease Specialist and Epidemiologist

Statement by the Dengue Vaccine Initiative on Mexico’s Regulatory Approval of Sanofi Pasteur’s Dengue Vaccine, Dengvaxia®

We're Not Winning This Fight

Read more News from IVAC →